Gene therapy for progressive familial intrahepatic cholestasis type 3 in a clinically relevant mouse model

Abstract

Progressive familial intrahepatic cholestasis type 3 is a disease caused by mutations in the gene encoding the multidrug resistance protein 3, and has limited treatment options. Here they show that adeno-associated virus mediated gene therapy prevents disease progression in a mouse disease model.